Knowledge Spillovers in Strategic Alliances
Author | : Suzanne E. Majewski |
Publisher | : |
Total Pages | : 58 |
Release | : 2002 |
Genre | : Biotechnology industries |
ISBN | : |
Download Strategic Alliances In Biotechnology full books in PDF, epub, and Kindle. Read online free Strategic Alliances In Biotechnology ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Suzanne E. Majewski |
Publisher | : |
Total Pages | : 58 |
Release | : 2002 |
Genre | : Biotechnology industries |
ISBN | : |
Author | : Hans-Werner Gottinger |
Publisher | : |
Total Pages | : 0 |
Release | : 2010 |
Genre | : Alliances stratégiques (Affaires). |
ISBN | : 9781608769971 |
This book covers a strategic industry analysis of a globally operating pharmaceutical and biotechnology industry. Both biotechnology and large pharmaceutical firms compete in a network industry characterised by rapid technological change which leads to industry change and market structure. In particular, these firms depend on the creation of new knowledge. New knowledge presents particular issues regarding transferability. Innovation potentials and alliance competencies should be prevalent in any market characterised by fast changing intangible assets , given the difficulties in trading intangibles; moreover, in industries with very high rates of technology change, technologies can be introduced that create new market segments, obsolesce existing product lines, and create substantial competitors from previously little-known firms.
Author | : Donald L. Drakeman |
Publisher | : Oxford University Press |
Total Pages | : 241 |
Release | : 2022 |
Genre | : Biotechnology industries |
ISBN | : 0195084004 |
"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Author | : Alice M. Sapienza |
Publisher | : Wiley-Liss |
Total Pages | : 226 |
Release | : 2001-04-09 |
Genre | : Business & Economics |
ISBN | : |
Nearly all pharmaceutical and biotechnology companies are forming strategic alliances, presenting formidable management challenges. "Leading Biotechnology Alliances: Right from the Start" provides immediately applicable tools for managing human relationships involved in these strategic alliances.
Author | : Mark De Rond |
Publisher | : Cambridge University Press |
Total Pages | : 252 |
Release | : 2003-06-19 |
Genre | : Business & Economics |
ISBN | : 9780521811101 |
How can we explain a proliferation of alliances when the probability of failure is higher than success? And why have we emphasized their order, manageability and predictability whilst acknowledging that they tend to be experienced as messy, politically charged and unpredictable? Mark de Rond, in this provocative book, sets out to address such paradoxes. Based on in-depth case studies of three major biotechnology alliances, he suggests that we need theories to explain idiosyncracy as well as social order. He argues that such theories must allow for social conduct to be active and self-directed but simultaneously inert and constrained, thus permitting voluntarism, determinism, and serendipity alike to explain causation in alliance life. The book offers a highly original combination of insights from social theory and intellectual history with more mainstream strategic management and organizations literature. It is a refreshing and thought-provoking analysis that will appeal to practitioner and academic researcher alike.
Author | : Suzanne Ellen Majewski |
Publisher | : |
Total Pages | : 254 |
Release | : 1998 |
Genre | : Biotechnology industries |
ISBN | : |
Author | : Sophie Veilleux |
Publisher | : |
Total Pages | : 17 |
Release | : 2010 |
Genre | : |
ISBN | : 9782895243496 |
Literature on strategic alliances in a context of biotechnology firms has been flourishing in recent years, addressing various aspects of these agreements. However, no study has specifically examined the characteristics of alliances in this sector, and more specifically, the composition of their portfolio of alliances. Based on the alliance portfolios of 28 biotech firms from Boston (U.S.) and Montreal (Canada), the present study demonstrates that these firms first and most frequently develop partnerships to assist them in their R&D function. University partners are more frequent and are used earlier in the firm?s development. Alliances with corporations start with production and marketing agreements with other SMEs, later turning to MNEs for additional marketing partnerships. Alliances are formed with domestic but mostly with international partners for all functions, types of R&D partners, and regardless of the size of the corporate partner.--Résumé de l'éditeur.
Author | : Suzanne E. Majewski |
Publisher | : |
Total Pages | : 39 |
Release | : 2002 |
Genre | : Biotechnology |
ISBN | : |